Monash IVF Group Ltd (FRA:MIS)

€ 0.74 0.02 (2.78%) Market Cap: 297.92 Mil Enterprise Value: 374.41 Mil PE Ratio: 0 PB Ratio: 1.82 GF Score: 53/100

Full Year 2024 Monash IVF Group Ltd Earnings Presentation Transcript
Aug 22, 2024
Monash IVF Group Ltd Annual Shareholders Meeting Transcript
Nov 28, 2023
Monash IVF Group Ltd Annual Shareholders Meeting Transcript
Nov 11, 2022
Full Year 2022 Monash IVF Group Ltd Earnings Call Transcript
Aug 26, 2022

€0.68 (-2.16%)

Earnings
Half Year 2022 Monash IVF Group Ltd Earnings Call Transcript
Feb 17, 2022

€0.685 (+0.74%)

Earnings
Monash IVF Group Ltd Annual Shareholders Meeting Transcript
Nov 19, 2021
Full Year 2021 Monash IVF Group Ltd Earnings Call Transcript
Aug 24, 2021

€0.59 (+4.42%)

Earnings
Monash IVF Group Ltd Annual Shareholders Meeting Transcript
Nov 26, 2020
Full Year 2020 Monash IVF Group Ltd Earnings Call Transcript
Aug 24, 2020

€0.36

Earnings
Half Year 2020 Monash IVF Group Ltd Earnings Call Transcript
Feb 20, 2020

€0.568672 (+0.83%)

Earnings

Half Year 2022 Monash IVF Group Ltd Earnings Call Transcript

Feb 17, 2022 / 12:30AM GMT

Release Date Price: €0.685 (+0.74%)

Transcript

Operator

Thank you for standing by, and welcome to the Monash IVF Group Half Year Results 2022 Conference Call. (Operator Instructions) I would now like to hand the conference over to Mr. Michael Knaap, CEO. Please go ahead.

Michael D. Knaap

Monash IVF Group Limited - CEO, MD & Director

Thank you, Matt, and good morning, and thank you all for joining us for our group's results presentation for the first half of FY '22. Our CFO, Malik Jainudeen, also joins me and will be later stepping us through the details of our financials. By way of background, Monash IVF is a market leader in providing reproductive care in our core assisted reproductive services, diagnostics, genetics and pathology services with a growing network of 48 IVF and women's ultrasound clinics and service centers across Australia and expanding in Southeast Asia.

Our experienced and capable team includes 132 doctors and in excess of 600 scientific, nursing and support staff. I would again like to take this opportunity to thank every one of our team for their unrelenting patient-first mindset

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.